Content-Length: 154786 | pFad | https://www.academia.edu/70677691/Synthesis_of_totarol

(PDF) Synthesis of (+)-totarol
Academia.eduAcademia.edu

Synthesis of (+)-totarol

2003, Tetrahedron Letters

Totarol, a tricyclic diterpene, has been synthesised from zamoranic acid. The key step is the cyclisation of a 13,14-secototarane using SmI 2 .

TETRAHEDRON LETTERS Pergamon Tetrahedron Letters 44 (2003) 8831–8835 Synthesis of (+)-totarol I. S. Marcos,* M. A. Cubillo, R. F. Moro, D. Dı́ez, P. Basabe, F. Sanz† and J. G. Urones Departamento de Quı́mica Orgánica, Facultad de Ciencias Quı́micas, Universidad de Salamanca, Plaza de los Caı́dos 1 -5, E-37008 Salamanca, Spain Received 28 July 2003; revised 18 September 2003; accepted 23 September 2003 Abstract—(+)-Totarol, a tricyclic diterpene, has been synthesised from zamoranic acid. The key step is the cyclisation of a 13,14-secototarane using SmI2. © 2003 Elsevier Ltd. All rights reserved. Totaranes, cleistantanes and cassanes are tricyclic diterpenes which are not very common in nature, but which show important biological activities as antiinflammatories, analgesics, antitumour agents, growth regulators and bacteriocides.1 All of them are characterized by having an alkyl group on C-14 and/or C-13 (methyl, ethyl or isopropyl). Zamoranic acid2 1 is a labdane diterpene used by us for the synthesis of biologically active natural products such as sesquiterpene drimanes,3 labdenolides such as limonidilactone,4 diterpenes with the isofregenedane skeleton such as chrysolic acid5 and tetracyclic diterpenes.6 Bearing in mind the following retrosynthetic scheme, biologically active diterpenes with the totarane, cassane or cleistantane skeleton could also be accessible from zamoranic acid. (Scheme 1). Thus, for the synthesis of tricyclic diterpenes II, secoderivatives I will be used as intermediates for cyclization via a pinacol coupling promoted by SmI2. This strategy will be applied to the synthesis of (+)totarol, a tricyclic diterpene with an aromatic ring C and a hydroxy group on C-13. (+)-Totarol is the main component of Podocarpus totara 7 and Podocarpus nagi 8 (Podocarpaceae) and shows potent activity against Gram-positive bacteria such as Propionibacterium acnes, Streptococcus mutans, Bacillus subtilis, Mycobacterium tuberculosis, Brevibacterium ammoniagenes and Staphylococcus aureus 9 (the last two being resistant to penicillin). (+)-Totarol shows synergy with other natu- Scheme 1. Keywords: diterpenes; zamoranic acid; totarol; samarium iodide. * Corresponding author. Tel.: +34-923-294474; fax: +34-923-294574; e-mail: ismarcos@usal.es † Servicio de rayos X, Universidad de Salamanca. 0040-4039/$ - see front matter © 2003 Elsevier Ltd. All rights reserved. doi:10.1016/j.tetlet.2003.09.193 8832 I. S. Marcos et al. / Tetrahedron Letters 44 (2003) 8831–8835 ral products such as anacardic acid, which results in the minimal antibacterial concentration (MBC) decreasing from 15.6 to 0.2 mg/ml.10 SAR studies with totarol and derivatives have shown totarol to be the most potent agent against Staphylococcus aureus.7,11 To the best of our knowledge there are only two syntheses of totarol;12 a new approach to (+)-totarol from zamoranic acid is shown in Schemes 2 and 3. Scheme 2. Reagents and conditions: (i) Ref. 6; (ii) rt, 40 min; (iv) (a) HMDSNa, TMSCl, −78°C, 2 MeOH, C6H6, rt, 12 h, (e) LiAlH4, Et2O, rt, 1 h; rt, 2 h, (c) K2CO3, MeOH, rt, 4 h, (d) CrO3, py, The transformation of the methyl ester of zamoranic acid 2 into the aldehyde 3 was previously reported by our group6 (Scheme 2). Addition of isopropylmagnesium chloride to aldehyde 3 proceeded with complete stereoselectivity to give exclusively the 14R-hydroxy derivative 4, in excellent yield. The structure of 4 was confirmed by X-ray analysis of one of its derivatives (compound 7, Scheme 2), showing that reaction of the iPrMgCl, THF, 0°C, 1 h; (iii) (a) Ac2O, py, 70°C, 2 h, (b) p-TsOH, Me2CO, h, (b) OsO4, NMO, rt, 48 h, (c) H5IO6, THF, H2O, rt, 1 h, (d) TMSCHN2, (v) TPAP, NMO, rt, 30 min; (vi) (a) Ac2O, py, rt, 30 min, (b) TPAP, NMO, rt, 1 h. Scheme 3. Reagents and conditions: (i) SmI2, THF, 0.1 M, MeOH, rt, 2 h; (ii) TPAP, NMO, 0°C, 30 min; (iii) p-TsOH, C6H6, 60°C, 48 h; (iv) (a) LDA, PhSeCl, THF, HMPA, −78 to 0°C, 1 h, (b) m-CPBA, DCM, rt, 5 min; (v) CuBr2, MeCN, 72 h, 50°C; (vi) Li2CO3, BrLi, DMF, 140°C, 16 h. I. S. Marcos et al. / Tetrahedron Letters 44 (2003) 8831–8835 nucleophile had taken place from the less hindered si face of the carbonyl group. The transformation of 4 into secototarane 6 through the methyl ketone 5 required acetylation at 70°C due to the hindrance of the hydroxyl group followed by deprotection. Degradation of 5 by the haloform reaction13 did not work and it was therefore necessary to employ a sequence of reactions. Thus, capture of the kinetic enolate of 5 as a trimethylsilyl enol ether14 and cishydroxylation, followed by cleavage with H5IO6,15 esterification16 of the resulting acid and reduction with LAH gave the diol 6 in excellent overall yield from 4. TPAP/NMO17 oxidation of 6 gave the lactone 7, whose structure was confirmed by single crystal X-ray structure determination (Fig. 1),18 corroborating the 14R configuration in 4. Due to this unwanted lactonization, the oxidation of 6 to the dicarbonyl system 8 needed for the cyclization was carried out in an indirect way: chemoselective acetylation of the primary hydroxyl group of 6 with Ac2O in pyridine over 30 min, oxidation of the secondary alcohol of the resulting monoacetyl derivative, hydrolysis of the primary acetoxy group, and subsequent oxidation which gave 8 (Scheme 2). Treatment of 8 with SmI219 (0.1 M, prepared in situ) gave a mixture of the totarane diastereomers 9 (80%) and 10 (13%), which were separated by column chromatography (Scheme 3). The structures of 9 and 10 were established by NMR, including HMQC, HMBC and nOe experiments. The signal for H-13 of 9 corresponded to an axial hydrogen (l 3.55, dd, J=11.1 and 4.1 Hz) and so the hydroxyl groups are both a. The signal for H-13 in 10 corresponds to an equatorial hydrogen (3.83 ppm, t, J=2.0 Hz). The structure for the major diol 9 is that expected from a pinacol coupling with SmI2.6 Transformation of 9 into totarol requires the dehydration of the tertiary hydroxy group and ring C aromatization. Oxidation of 9 with TPAP/NMO gave 11 in 8833 good yield, but all attempts to dehydrate and aromatize 11 using different conditions and reagents (DDQ,20 TsCl/py, POCl3/py, SOCl2/py, HClO4, CF3COOH, HCOOH, HI) failed to give the desired results. The aromatization of ring C was therefore attempted from ketone 12, obtained by pinacol rearrangement from 9. Treatment of 9 with p-TsOH, and subsequent column chromatography, gave 12 (61%) and the minor compounds 13 and 14. The formation of the cyclohexanone 12 can be explained by the migration of hydride from C-13 to C-14, although under the acidic conditions of the reaction, epimerization at C-14 takes place to provide the more stable b-isopropyl group. The aldehyde 13 is formed by ring C contraction in the pinacol reaction and compound 14 is a dimer (M+ m/e: 580) formed by reaction of the starting material with the aldehyde 13. The aromatization of 12 was attempted via enone 15, obtained by reaction of 12 with PhSeCl/LDA21 followed by oxidation of the selenide with m-CPBA at 0°C. All attempts at aromatization of 15 with DDQ, SeO2 at 0°C or even Pd/C22 in refluxing m-xylene failed to give totarol. Aromatization of ring C was finally achieved by a halogenation–dehydrohalogenation sequence via intermediate 16. Treatment of 12 with CuBr2/MeCN23 gave the dibromide 16 in moderate yield, and subsequent elimination with Li2CO3/LiBr24 gave a good yield of 1725 [mp 129–130°C; [h]25 D +41 (c 0.4, CHCl3)], whose spectroscopic properties were coincident with those of (+)-totarol; (lit.7b) mp 131–132°C, [h]25 D +42 (c 0.8, CHCl3). With the synthesis of (+)-totarol from zamoranic acid, we have opened a new synthetic route to tricyclic diterpenes with alkyl groups at C-14 (totaranes, cassanes or cleistantanes) using the cyclization of their 13,14-seco derivatives. Acknowledgements The authors thank the Spanish DGI for financial support (BQU2002-02049) for a doctoral fellowship to M.A.C. and Junta de Castilla y León for financial support (SA075/03). References Figure 1. ORTEP view of compound 7. 1. (a) Hanson, J. R. Nat. Prod. Rep. 2002, 19, 125; (b) ApSimon, J. The Total Synthesis of Natural Products; John Wiley and Sons: New York, 1992; Vol. 8, p. 2; (c) Ying, B.-P.; Kubo, I. Phytochemistry 1991, 30, 1951; (d) Jiang, R.-W.; But, P. P.-H.; Ma, S.-C.; Ye, W.-C.; Chan, S.-P.; Mak, T. C. W. Tetrahedron Lett. 2002, 43, 2415; (e) Pinto, A. C.; Macaira, A. P. Phytochemistry 1988, 27, 3974. 8834 I. S. Marcos et al. / Tetrahedron Letters 44 (2003) 8831–8835 2. de Pascual Teresa, J.; Urones, J. G.; Marcos, I. S.; Dı́ez, D.; Alvarez, V. Phytochemistry 1986, 25, 711. 3. (a) Marcos, I. S.; Moro, R. F.; Carballares, S.; Urones, J. G. Synlett 2000, 541; (b) Urones, J. G.; Marcos, I. S.; Pérez, B. G.; Lithgow, A.; Dı́ez, D.; Gómez, P. M.; Basabe, P.; Garrido, N. M. Tetrahedron 1995, 51, 1845; (c) Urones, J. G.; Dı́ez, D.; Gómez, P. M.; Marcos, I. S.; Basabe, P.; Moro, R. F. J. Chem. Soc., Perkin Trans. 1 1997, 1815; (d) Urones, J. G.; Dı́ez, D.; Gómez, P. M.; Marcos, I. S.; Basabe, P.; Moro, R. F. Nat. Prod. Lett. 1998, 11, 145; (e) Urones, J. G.; Marcos, I. S.; Pérez, B. G.; Lithgow, A.; Dı́ez, D.; Basabe, P.; Gómez, P. M. Tetrahedron Lett. 1994, 35, 3781; (f) Urones, J. G.; Marcos, I. S.; Pérez, B. G.; Dı́ez, D.; Lithgow, A.; Gómez, P. M.; Basabe, P.; Garrido, N. M. Tetrahedron 1994, 37, 10995. 4. Marcos, I. S.; Moro, R. F.; Carballares, S.; Urones, J. G. Tetrahedron Lett. 1999, 40, 2615. 5. Marcos, I. S.; Laderas, M.; Dı́ez, D.; Basabe, P.; Moro, R. F.; Garrido, N. M.; Urones, J. G. Tetrahedron Lett. 2003, 44, 5419. 6. Marcos, I. S.; Moro, R. F.; Carballares, S.; Urones, J. G. Synlett 2002, 458. 7. (a) Evans, G. B.; Furneaux, R. H.; Gravestock, M. B.; Lynch, G. P.; Scott, G. K. Bioorg. Med. Chem. 1999, 7, 1953; (b) Hodges, R. J. Chem. Soc. 1961, 4247. 8. (a) Cambie, R. C.; Cox, R. E.; Croft, K.-D.; Sidwell, D. Phytochemistry 1983, 22, 1436; (b) Kubo, I.; Muroi, H.; Himejima, M. J. Nat. Prod. 1992, 55, 1436. 9. Kubo, I.; Muroi, H. M.; Kubo, A. J. Nat. Prod. 1994, 57, 9. 10. Bernabeu, A.; Shapiro, S.; Villalaı́n, J. Chem. Phys. Lipids 2002, 119, 33. 11. (a) Evans, G. B.; Furneaux, R. H. Bioorg. Med. Chem. 2000, 8, 1653; (b) Evans, G. B.; Furneaux, R. H.; Gainsford, G. J.; Murphy, M. P. Bioorg. Med. Chem. 2000, 8, 1663. 12. (a) Barltrop, J. A.; Rogers, N. A. J. Chem. Ind. 1957, 20; (b) Barltrop, J. A.; Rogers, N. A. J. J. Chem. Soc. 1957, 2566; (c) Matsumoto, T.; Suetsugu, A. Bull. Chem. Soc. Jpn. 1979, 52, 1450. 13. (a) Ohloff, G.; Vial, C. Helv. Chim. Acta 1980, 63, 1932; (b) Kiruchi, T.; Kadota, S.; Suehara, H.; Namba, T. Tetrahedron Lett. 1981, 22, 465; (c) Harding, K. E.; Clement, K. S. J. Org. Chem. 1984, 49, 2049; (d) He, J.-F.; Wu, Y.-L. Tetrahedron 1988, 44, 1933; (e) Nussbaumer, C.; Frater, G.; Kraft, P. Helv. Chim. Acta 1999, 82, 1016. 14. (a) Brownbridge, P. Synthesis 1981, 1; (b) Corey, E. J.; Gross, A. W. Tetrahedron Lett. 1984, 25, 495. 15. (a) Marcos, I. S.; Moro, R. F.; Carballares, S.; Urones, J. G. Tetrahedron 2001, 57, 713; (b) Schröder, M. Chem. Rev. 1980, 80, 187; (c) Lohray, B. B. Tetrahedron: Asymmetry 1992, 3, 1317; (d) For a review, see: Haines, A. H. In Comprehensive Organic Synthesis; Trost, B. M.; Fleming, I., Eds. Addition Reactions with Formation of Carbon–Oxygen Bonds. (iii) Glycol Forming Reactions; Pergamon Press: Oxford, 1991; Vol. 7, p. 437; (e) Thomas, A. F.; Vial, C.; Ozainne, M.; Ohloff, G. Helv. Chim. Acta 1973, 56, 2270. 16. (a) Shioiri, T.; Aoyama, T.; Mori, S. In Org. Synth. Coll. Vol. VIII; Freeman, J. P., Ed.; John Wiley and Sons: New York, 1993; p. 612; (b) Miwa, K.; Aoyama, T.; 17. 18. 19. 20. 21. 22. 23. 24. 25. Shioiri, T. Synlett 1994, 107; (c) Paquette, L. A. In Encyclopedia of Reagents for Organic Synthesis; John Wiley and Sons: New York, 1995; p. 5248; (d) Bergamin, P.; Bortolini, O.; Costa, E.; Pringle, P. G. Inorg. Chim. Acta 1996, 252, 33. Ley, S. V.; Norman, J.; Griffith, W. P.; Marsden, S. P. Synthesis 1994, 639. A suitable single crystal of 7 was subjected to X-ray diffraction studies on a Seifert 3003 SC rotating anode diffractometer with (Cu Ka) radiation (graphite monochromator) using 2q0 scans at 293(2) K. Crystal data for 7: C20H34O2, M=306.47, monoclinic, space group P21 (No. 4), a=8.816(2), b=8.495(2), c=13.555(3) A, , h=k=90°, i=105.42(3)°, V=908.7(3) A, 3, Z=2, Dcalcd=1.120 Mg/m3, m=(Cu Ka)=0.070 mm−1, F(000)=340. 1453 reflections were collected, of which 1315 were considered to be observed with I>2|(I). The structure was determined by direct methods using the SHELXTL™ suite of programs. The positions of the hydrogen atoms were located from difference Fourier method and refined isotropically. Full-matrix leastsquares refinement based on F 2 with anisotropic thermal parameters for the non-hydrogen atoms led to agreement factors R1=0.0326 and wR2=0.0797. Crystallographic data (excluding structure factors) for the structure reported in this paper have been deposited at the Cambridge Crystallographic Data Centre as supplementary material no. CCDC 213752. (a) Girard, P.; Namy, J. L.; Kagan, H. B. J. Am. Chem. Soc. 1980, 9, 2093; (b) Chiara, J.; Martı́n-Lomas, M. Tetrahedron Lett. 1994, 35, 2969; (c) Molander, G. A.; Harris, C. R. Chem. Rev. 1996, 96, 307; (d) Kornienko, A.; Alarcao, M. Tetrahedron Lett. 1997, 38, 6497; (e) Adinolfi, M.; Barone, G.; Ladonisi, A.; Mangoni, L.; Manna, R. Tetrahedron Lett. 1997, 38, 11767; (f) Boiron, A.; Zillig, P.; Faber, D.; Giese, B. J. Org. Chem. 1998, 63, 5877. DDQ: (a) Hattori, T.; Date, M.; Sakurai, K.; Morohashi, N.; Kosugi, H.; Miyano, S. Tetrahedron Lett. 2001, 42, 8035; (b) Ray, J. K.; Gupta, S.; Kar, G. K.; Roy, B. C.; Lin, J.-M.; Amin, S. J. Org. Chem. 2000, 65, 8134. (a) Rastetter, W. H.; Nachbar, R. B.; Russo-Rodrı́guez, S.; Wattley, R. V. J. Org. Chem. 1982, 47, 4873; (b) Ando, M.; Wada, T.; Kusaka, H.; Takase, K.; Hirata, N.; Yanagi, Y. J. Org. Chem. 1987, 52, 4792; (c) Monsun, K.; Kawada, H.; Gross, R. S.; Watt, D. S. J. Org. Chem. 1990, 55, 504; (d) Urones, J. G.; Basabe, P.; Marcos, I. S.; Dı́ez Martı́n, D.; Sexmero, M. J.; Peral, M. H. Tetrahedron 1992, 48, 10389. (a) Theissen, R. J. J. Org. Chem. 1971, 36, 752; (b) Pelcman, B.; Gribble, G. W. Tetrahedron Lett. 1990, 31, 2381; (c) Nelson, P. H.; Nelson, J. T. Synthesis 1991, 192. Evans, G. B.; Furneaux, R. H.; Gravestock, M. B.; Lynch, G. P.; Scott, G. K. Bioorg. Med. Chem. 1999, 7, 1953. (a) Paquette, L. A. Encyclopedia of Reagents for Organic Synthesis; John Wiley and Sons: New York, 1995; p. 3062; (b) Vidari, G.; Ferrino, S.; Grieco, P. A. J. Am. Chem. Soc. 1984, 106, 3539; (c) Wang, X.; Paquette, L. A. Tetrahedron Lett. 1993, 34, 4579. Mp: 129–130°C (n-hexane); [h]25 D +41 (c 0.4, CHCl3); IR wmax (film) cm−1: 3482, 2932, 1458, 1387, 1263, 1103, 665. The assignments for the spectra, 1H and 13C NMR, for I. S. Marcos et al. / Tetrahedron Letters 44 (2003) 8831–8835 17 were carried out using two-dimensional HMQC and HMBC experiments. 1H NMR (200 MHz, CDCl3, l ppm): 7.00 (1H, d, J=8.4 Hz, H-12), 6.51 (1H, d, J= 8.4 Hz, H-11), 3.41 (1H, m, H-15), 3.00–2.80 (2H, m, H-7), 2.30–1.20 (9H, m), 1.33 (3H, d, J=7.0 Hz, H-16), 1.32 (3H, d, J=7.0 Hz, H-17), 1.17 (3H, s, Me-20), 0.94 (3H, s, Me-18) and 0.90 (3H, s, Me-19); 13C NMR 8835 (50 MHz, CDCl3, l ppm): 152.1 (C-13), 143.3 (C-9), 133.9 (C-8), 131.1 (C-14), 123.1 (C-11), 114.5 (C-12), 49.7 (C-5), 42.0 (C-3), 39.8 (C-1), 38.0 (C-10), 33.5 (C4), 33.4 (C-18), 28.9 (C-7), 27.3 (C-15), 25.4 (C-20), 21.8 (C-19), 20.6 (C-16 and C-17), 19.8 (C-2), 19.6 (C6); EIHRMS: calcd for C20H30O (M+): 286.2297, found 286.2292.








ApplySandwichStrip

pFad - (p)hone/(F)rame/(a)nonymizer/(d)eclutterfier!      Saves Data!


--- a PPN by Garber Painting Akron. With Image Size Reduction included!

Fetched URL: https://www.academia.edu/70677691/Synthesis_of_totarol

Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy